Efficacy and safety of D-penicillamine, trientine, and zinc in pediatric Wilson disease patients.

Eun Joo LeeMin Hyung WooJin Soo MoonJeong Kee Seo

Published in: Orphanet journal of rare diseases (2024)

In pediatric WD, DPA, zinc, and trientine have therapeutic effects in that order. However, DPA and zinc are associated with more adverse effects compared to trientine.

Keyphrases

end stage renal disease
oxide nanoparticles
ejection fraction
chronic kidney disease
patient reported outcomes
young adults
patient reported